Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-dense cyclophosphamide for TP53-mutated advanced breast cancer (p53 trial)
2016-003459-31Phase 2Active
- Sponsor
- Helse Bergen
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in breast cancer, sponsored by Helse Bergen. Started Aug 2016; status: active.
02
Drugs
cyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2016-003459-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003459-31.